H. Samonigg
Impact in
- Oncology top 1%
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 41
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 7
- Inflammatory Biomarkers in Disease Prognosis 5
-
- Breast Cancer Treatment Studies 16
- Co-authors
- Armin Gerger (10 shared papers)Michael Stotz (8 shared papers)Joanna Szkandera (7 shared papers)Tatjana Stojaković (6 shared papers)Gudrun Absenger (6 shared papers)Michael Gnant (24 shared papers)Martin Pichler (8 shared papers)R. Jakesz (21 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)British Journal of Cancer (12 papers)European Journal of Cancer (9 papers)Cancer Research (4 papers)British Journal of Dermatology (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
H. Samonigg
73 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 108
- Oncology 1.5k
- Cancer Research 690
- Hematology 254
- Genetics 374
- Internal Medicine 39
Countries citing papers authored by H. Samonigg
This map shows the geographic impact of H. Samonigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Samonigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Samonigg more than expected).
Fields of papers citing papers by H. Samonigg
This network shows the impact of papers produced by H. Samonigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Samonigg. The network helps show where H. Samonigg may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Samonigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 272 | |
| 2 | 2007 | 229 | |
| 3 | 2013 | 183 | |
| 4 | 2013 | 164 | |
| 5 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 2001 | 164 |
| 6 | 1994 | 153 | |
| 7 | 2013 | 129 | |
| 8 | 1994 | 108 | |
| 9 | 2005 | 104 | |
| 10 | 2007 | 82 | |
| 11 | 2012 | 81 | |
| 12 | 2013 | 79 | |
| 13 | 2003 | 63 | |
| 14 | 2008 | 63 | |
| 15 | 2015 | 60 | |
| 16 | 2005 | 56 | |
| 17 | 2009 | 55 | |
| 18 | 2013 | 46 | |
| 19 | 1999 | 46 | |
| 20 | 2013 | 43 |
About H. Samonigg
H. Samonigg is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 77 papers that have together received 2.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (13 papers), Advanced Breast Cancer Therapies (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Estrogen and related hormone effects (7 papers), Genetic factors in colorectal cancer (7 papers), Immunotherapy and Immune Responses (5 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (690 citations), Hematology (254 citations), Genetics (374 citations) and Internal Medicine (39 citations). H. Samonigg has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Armin Gerger, Michael Stotz, Joanna Szkandera, Tatjana Stojaković, Gudrun Absenger, Michael Gnant, Martin Pichler, R. Jakesz, Renate Schaberl-Moser and E. Kubista. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer, Cancer Research and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.